(Q53527046)

15 May 2018

title

Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. (English)

1 reference

15 May 2018

1 reference

Han-Shui Hsu

1

1 reference

15 May 2018

Tsz-Pei Chen

2

1 reference

15 May 2018

Chein-Hui Hung

3

1 reference

15 May 2018

Chiao-Kai Wen

4

1 reference

15 May 2018

Rou-Kai Lin

5

1 reference

15 May 2018

Hui-Chen Lee

6

1 reference

15 May 2018

Yi-Ching Wang

7

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 November 2007

1 reference

15 May 2018

published in

Cancer

1 reference

15 May 2018

volume

110

1 reference

15 May 2018

issue

9

1 reference

15 May 2018

page(s)

2019-2026

1 reference

15 May 2018

Multidisciplinary management of lung cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

Annual screening using chest x-ray examination for the diagnosis of lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

Sputum occult blood screening for lung cancer. Stage II screening of 14,431 subjects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

In vitro induction of myeloid leukemia-specific CD4 and CD8 T cells by CD40 ligand-activated B cells gene modified to express primary granule proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

Alterations of the p16(ink4a) gene in resected nonsmall cell lung tumors and exfoliated cells within sputum

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

Gene promoter methylation in plasma and sputum increases with lung cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23001

7 January 2021

Identifiers

DOI

10.1002/CNCR.23001

1 reference

15 May 2018

1 reference

15 May 2018